Continuing out Core Story program, today’s exploration is a company we just can’t get enough of, Medexus Pharmaceuticals (MDP.T). CEO Ken D’Entremont has nailed his milestones the last 18…
roll-up
C21 Investments (CXXI.C) is shaking things up in Oregon. The company announced Dec. 29 it is reorganizing its management structure in the Pacific Northwest state and terminating its discussions…
2018 was a monumental year for C21 Investments (CXXI.C). After acquiring a tonne of subsidiaries in Oregon and Nevada over the past few months, C21 learned in November it was…
C21 Investments (CXXI.C) has been on a tear, snapping up value-adding acquisitions on its quest to become the cannabis industry’s Coca-Cola (KO.Z). With a series of buys already under…
One thing I love about US-focused cannabis roll-up C21 Investments (CXXI.C) is their ‘coming through’ attitude. They’re buying up US weed assets quickly, and don’t mess around with small…
Way back in 2014, when a shift in Canadian laws made marijuana companies a thing you could invest in, I pointed out to anyone who’d listen that, sure, growing…